Company intelligence / Profile preview

Beyond Air

Garden City, New York, United Statesbeyondair.net ↗
Ownership
Public · XAIR
Employees
~107
Development stage
Other
01

Overview

Beyond Air has commercialized its LungFit® PH system in the US and EU for neonatal hypoxic respiratory failure. The company’s pipeline includes clinical-stage programs targeting severe lung infections such as NTM with high-concentration iNO, as well as preclinical/early clinical drug candidates like an nNOS inhibitor for ASD. Its affiliate Beyond Cancer Ltd. is advancing ultra-high concentration NO immunotherapy in Phase I trials for solid tumors. Recent data show safety and efficacy signals in chronic refractory NTM patients using LungFit GO at home[8].

Therapeutic areas
PulmonologyPsychiatryCardiovascularOncologyNeurologyInfectious Diseases
Modalities
Inhaled nitric oxide (iNO) therapy (device-based)Small molecule nNOS inhibitor (drug candidate)Ultra-high concentration nitric oxide immunotherapy
Industry
Biotech
02

Drug pipeline

3 assets

nitric oxide (Beyond Air)

Approved

2 more assets in the full pipeline.

03

Partnerships

Getz Healthcare—Asia-Pacific distribution partner for LungFit PH[9].The Hebrew University of Jerusalem—pre-clinical collaboration on ASD/nNOS program[7].
04

Financials

Market cap
$1.4M
Total revenue
$7.7M
Enterprise value
$9.8M

Beyond the preview

Go deeper on Beyond Air.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beyond Air.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call